1

QL1604 combined with bevacizumab as an innovative first-line treatment for HCC patient with extensive metastasis who showed remarkable effect: a case report

rssylelpga41hq
Hepatocellular carcinoma (HCC) is a common and highly malignant tumor with poor outcomes. especially when it metastasizes. In this report. we present the case of a 64-year-old male patient diagnosed with recurrence and multiple metastases of HCC 7 years after surgery. https://www.parisnaturalfoodes.shop/product-category/kids-toothgel/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story